| Name | Recombinant Human Angiopoietin-4 Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 964-AN/CF |
| Category | Protein |
| Prices | $359.00 |
| Sizes | 25 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Human Ang-4 (Gln23 - Ile503) or (Gln24 - Ile503) Accession # Q9Y264 IEGR GGGSGGGSGGGS 10-His tag N-terminus C-terminus |
| Purity | >85%, by SDS-PAGE under reducing conditions and visualized by silver stain |
| Bioactivity | Measured by its ability to compete with biotinylated rhAng-2 for binding to immobilized Tie-2/Fc Chimera in a functional ELISA. Compared to rmAngiopoietin-3, rhAngiopoietin-4 is less effective in this competitive assay. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | Q9Y264 |
| Gene | ANGPT4 |
| Sequence | No results obtained: Gln23 or Gln24 predicted |
| Supplier Page | Shop |
Brunckhorst MK, Xu Y, Lu R, Yu Q. Am J Pathol. 2014 Aug;184(8):2285-96.
Brunckhorst MK, Wang H, Lu R, Yu Q. Cancer Res. 2010 Sep 15;70(18):7283-93.